Company Information
CIN
Status
Date of Incorporation
17 April 2007
State / ROC
Delhi / ROC Delhi
Industry
research and experimental development on natural sciences and engineering
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
14,014,180
Authorised Capital
36,783,000
Past Directors
Patents
The present invention discloses compounds useful in treatment of conditions associated with excessive activity of transforming growth factor beta (TGF-P), particularly type 1 or activin-like kinase 5 (ALK 5). Specifically the present invention discloses compound of formula (I) which exhibit inhibitory activity again...
The present disclosure relates generally to compounds useful in treatment of conditions associated with mutant isocitrate dehydrogenase (mt-IDH), particularly mutant IDH1 enzymes. Specifically, the present invention discloses compound of formula (IA), which exhibits inhibitory activity against mutant IDH1 enzymes. M...
The present disclosure relates generally to compounds useful in treatment of conditions associated with Checkpoint kinase (CHK), particularly CHK-1 enzymes. Specifically, the present invention discloses compound
of formula (IA), which exhibits inhibitory activity against CHK-1 enzymes. Methods of treating condition...
The present disclosure relates generally to compounds useful in treatment of conditions associated with Checkpoint kinase (CHK), particularly CHK-1 enzymes. Specifically, the present invention discloses compound of formula (J), which exhibits inhibitory activity against CHK-1 enzymes. Methods of treating conditions ...
Trademarks
[Class : 5] Pharmaceutical And Medicinal Preparations.
[Class : 42] Scientific Research Services For Medical Purposes And Research & Development Of New Products For Others.
[Class : 1] Chemicals And Chemical Compounds.
